RCHOP is a treatment for DLBCL , follicular lymphoma and other B cell lymphomas that the guidelines recommend for frontline treatment.
July 23
R-CHOP is primarily used to treat Diffuse Large B-Cell Lymphoma (DLBCL), which is one of the most common types of Non-Hodgkin Lymphoma (NHL). It's considered the standard first-line treatment, meaning it's typically the first option doctors turn to after diagnosis. R-CHOP is a combination of five drugs:
- R — Rituximab, an Show Full Answer
R-CHOP is primarily used to treat Diffuse Large B-Cell Lymphoma (DLBCL), which is one of the most common types of Non-Hodgkin Lymphoma (NHL). It's considered the standard first-line treatment, meaning it's typically the first option doctors turn to after diagnosis. R-CHOP is a combination of five drugs:
- R — Rituximab, an immunotherapy that targets B cells
- C — Cyclophosphamide, a chemotherapy drug
- H — Doxorubicin, a chemotherapy drug
- O — Vincristine, a chemotherapy drug
- P — Prednisone, a steroid
It's generally given in six cycles over about 18 weeks and can cure roughly 60–70% of newly diagnosed DLBCL cases. It's worth noting that R-CHOP isn't a one-size-fits-all solution. Some subtypes of DLBCL, like double-hit lymphoma, may require more intensive treatment. Always worth having a detailed conversation with your doctor about what's right for your specific situation.
May 3
Join
Your Privacy Choices
